Another case of drug-resistant fungal superbug has been reported in an American state.
Oregon health officials have announced three cases of Candida auris, a rare fungal infection that the Centers for Disease Control and Prevention (CDC) have described as posing a “serious” concern for the world.
Officials in Oregon confirmed three of the victims on Tuesday. On December 11, the first case was identified. The next two cases were discovered in the weeks that followed. Salem Health in Salem (Oregon) was affected by the epidemic.
A patient was the first to be diagnosed with this condition. “recent international healthcare exposures,”Officials.
Candida auris first became known in 2009. However, it did not become widespread in the US until 2013. According to the CDC, there have been over 1,100 confirmed cases and probable cases. The most reported cases were from Texas, New York and Illinois. California, Florida, and California had 135-285.
Candida auris, according to the CDC is a serious infection. “presents a serious global threat”It is mostly transmitted locally by healthcare providers. The virus can be highly transmitted and cause serious complications. “invasive infections”In 5-10% to 10% of people affected. The symptoms include chills and fever. It can also spread to nearby people through close contact or contamination.
READ MORE
CDC alerts about drug-resistant fungal infections in Texas and DC hospitals
Salem Health’s medical director for infection prevention, Jasmin Chaudhary said that the Covid-19 epidemic has resulted in a “rise in multi-drug resistant organisms” like Candida auris.
Oregon Health officials warn that this infection is a serious concern “particularly”Causes serious infections for those with an existing condition “serious medical problems.”
This story can be shared on social media
[ad_2]
